Colorectal cancer screening in asymptomatic adults: Comparison of colonoscopy, sigmoidoscopy and fecal occult blood tests

Journal of the Formosan Medical Association

Volumn 101, Issue 10, 2002, Pages 685-690

  Cheng, Tsun I ^b   Wong, Jau Min ^a   Hong, Cheng Fang ^b   Cheng, Skye H ^b   Cheng, Tsun Jen ^a   Shieh, Ming Jium ^a   Lin, Yue Mong ^b   Tso, C Y ^b   Huang, Andrew T ^b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b KOO FOUNDATION SUN YAT SEN CANCER CENTER   (Taiwan)

Author keywords

Colonoscopy; Colorectal neoplasms; Occult blood; Polyps; Sigmoidoscopy

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BLOOD ANALYSIS; CANCER PATIENT; CANCER SCREENING; CHEMICAL ANALYSIS; CLINICAL EXAMINATION; CLINICAL FEATURE; COLON POLYP; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; DESCENDING COLON; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DISEASE SEVERITY; FAMILY STUDY; FEMALE; HEALTH PROGRAM; HUMAN; IMMUNOLOGICAL PROCEDURES; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; OCCULT BLOOD; PATHOLOGICAL ANATOMY; PREVALENCE; SIGMOIDOSCOPY; SYMPTOM; TAIWAN;

ADULT; AGED; AGED, 80 AND OVER; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; SIGMOIDOSCOPY;

EID: 0036818937     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Department of Health: Leading causes of death from cancer, Taiwan area. Health and vital statistic 19991:73.
2. Department of Health: Leading causes of death from cancer, Taiwan area. Health and vital statistic 2000:77.
3. Morson BC: The poly-cancer sequence in the large bowel. Proc R Soc Med 1974;67:451-7.
4. Fearon ER, Hamilton SR, Vogelstein B: Clonal analysis of human colorectal tumors. Science 1987;238:193-7.
5. Stryker SJ, Wolff BG, Culp CE, et al: Natural history of untreated colonic polyps. Gastroenterology 1987;93: 1009-13.
6. Mandell JS, Bond JH, Church TR, et al: Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993;328:1365-71.
7. Hardcastle JD, Chamberlain JO, Robinson MHE, et al: Randomized controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7.
8. Kronborg O, Fenger C, Olsen J, et al: Randomized study of screening for colorectal cancer with faecal-occult blood test. Lancet 1996;348:1467-71.
9. Selby JV, Friedman GD, Quesenberry CP Jr, et al: A case-control study of screening sigmiodoscopy and mortality from colocteral cancer. N Engl J Med 1992; 326:653-7.
10. Newcomb PA, Norfleet RG, Storer BE, et al: Screeing sigmiodoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992;84:1572-5.
11. Muller AD, Sonnenberg A: Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans. Ann Intern Med 1995; 123:904-10.
12. Winawer SJ, Fletcher RH, Miller L, et al: Colorectal cancer screening clinical guidelines and rationale. Gastroenterology 1997;112:594-642.
13. Byers T, Levin B, Rothenberger D, et al: American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997. CA Cancer J Clin 1997;47:154-60.
14. Lieberman DA, Weiss DG, Bond JH, et al: Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veteran Affairs Cooperative Study Group 380. N Engl J Med 2000;343:162-8.
15. Imperiale TF, Wagner DR, Lin CY, et al: Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med 2000;343: 169-74.
16. Lieberman DA, Weiss DG: One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med 2001;345:555-60.
17. Chen TH, Yen MF, Lai MS, et al: Evaluation of a selective screening for colorectal carcinoma, the Taiwan multi-center cancer screening (TAMCAS) project. Cancer 1999; 86:1116-28.
18. Shieh MJ, Wang CY, Wong JM, et al: Colonoscopic screening for families of patients with colorectal cancer. J Formos Med Assoc 1996;95:828-32.
19. Correa P: Epidemiology of polyps and cancers. In: Morson BC, ed. The Pathogenesis of Colorectal Cancer. Philadelphai: WB Saunders, 1978:126-52.
20. Correa P, Strong JP, Reif A, et al: The epidemiology of colorectal polyps: prevalence in New Orleans and international comparisons. Cancer 1977;38:2258-64.
21. Clark JC, Collan Y, Eide TJ, et al: Prevalence of polyps in an autopsy series from areas with varying incidence of large-bowel cancer. Int J Cancer 1985;36:179-86.
22. Doll R: The age distribution of cancer: implications for model of carcinogenesis. R Statist Soc A 1971;134: 133-66.
23. Ransohoff DF, Lang CA: Screening for colorectal cancer with fecal occult blood test: a background paper. Ann Intern Med 1997;126:811-22.
24. Hardcastle JD, Thomas WM, Chamberlain J, et al: Randomized, controlled trial of fecal occult blood screening for colorectal cancer. Result of first 107,349 subjects. Lancet 1989;i:1160-4.
25. Hardcastle JD, Justin TA: Screening high-risk groups for colorectal neoplasia. Am J Gastroenterol 1996;91: 850-2.
26. Kewenter J, Brevinge H, Engaras B, et al: Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68,308 subjects. Scand J Gastroenterol 1994;29:468-73.
27. Kewenter J, Bjock S, Haglind E, et al: Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,770 subject. Cancer 1998; 62:645-51.
28. Kronborg O, Fenger C, Olsen J, et al: Repeated screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen, Denmark. Scand J Gastroenterol 1989;24:599-606.
29. Ransohoff DF, Lang CA: Improving the fecal blood test. N Engl J Med 1996;334:189-90.
30. St. John DJ, Young GP, Alexeyeff MA, et al: Evaluation of new occult blood test for detection of colorectal neoplasia. Gastroenterology 1993;104:1661-8.
31. Thomas WM, Hardcastle JD, Jackson J, et al: Chemical and immunological testing for fecal occult blood: a comparison of two test in symptomatic patients. Br J Cancer 1992;65:618-20.
32. Zappa M, Castiglione G, Paci E, et al: Measuring interval cancers in population-based screening using different assays of fecal occult blood testing: the district of Florence experience. Int J Cancer 2001;92: 151-4.